Navigation Links
U of MN researchers reverse memory loss in mice

Researchers at the University of Minnesota were able to reverse memory loss in mice with significant brain degeneration for the first time, a breakthrough that offers hope to the estimated 4 million people living with Alzheimer's disease.

Researchers first manipulated the genetic makeup of the mice so they developed dementia; the mice experienced memory loss that worsens over time and had brain atrophy similar to what a person with Alzheimer's disease goes through. The researchers further designed the mice so that the transgene that causes these symptoms could be "turned off." Transgenes are genes from one organism that have been incorporated into another organism.

The researchers predicted that when the transgene expressing the dementia was turned off, memory loss would stop. The results, however, surpassed their expectations. The mice's symptoms of dementia were reversed--in other words, they regained memory.

"Most Alzheimer's disease treatments focus on slowing the symptoms or preventing the disease from progressing, but our research suggests that in the future we may be able to reverse the effects of memory loss, even in patients who have lost brain or neural tissue," said Karen Ashe, professor of neurology and lead author of the study.

The results will be published in the July 15 issue of the journal Science.

In the past, it was generally accepted that dementia was caused by two substances that accumulate in the brain: neurofibrillary tangles, which are tangled bundles of fibers in neurons, and amyloid deposits, a toxic build-up of plaque in the brain. The researchers found that even after the memory loss was regained in the mice, the tangles remained, and even increased in number. This suggests that the tangles are not a cause of dementia as previously thought.

The mice serve as a model that shows how the disease progresses as well as the possibility that memory loss can be reversed. The research suggests that the same reversal may be possible in humans, and that people with Alzheimer's disease may be able to recover memory and improve in cognitive function if they can halt progression of the disease.

The study measured the mice's spatial memory through a water maze--a pool of water with a submerged platform. The use of this maze taps into the hippocampus, an area of the brain important in Alzheimer's disease research.

Since mice are not fond of water, they will swim to find the platform. First the mice were put in the pool and allowed to learn where the platform is located. After they learn where the platform is, the platform is removed, and the mice are again put in the pool. The researchers measured how much time the mice spent swimming in the area where the platform should have been.

Since the mice were designed to develop dementia, over time they forget where the platform should be and swim aimlessly around the pool. After the researchers turn off the gene expressing the memory loss, the same mice that swam aimlessly around the pool would again concentrate their search on the area of the pool where the platform was located, thus showing memory recovery.

Researchers from the Department of Neuroscience at Mayo Clinic Jacksonville, and the Department of Neurology at Massachusetts General Hospital contributed to the study.


'"/>

Source:University of Minnesota


Related biology news :

1. NYU researchers simulate molecular biological clock
2. Vital step in cellular migration described by UCSD medical researchers
3. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
4. UCSD researchers maintain stem cells without contaminated animal feeder layers
5. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
6. New protein discovered by Hebrew University researchers
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Agilent Technologies releases automated literature search tool for biology researchers
9. Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin
10. Yale researchers identify molecule for detecting parasitic infection in humans
11. US life expectancy about to decline, researchers say
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: